74 related articles for article (PubMed ID: 8731465)
1. Recall performance in acutely depressed patients and plasma cortisol.
Bemelmans KJ; Goekoop JG; van Kempen GM
Biol Psychiatry; 1996 Apr; 39(8):750-2. PubMed ID: 8731465
[No Abstract] [Full Text] [Related]
2. Asymmetry of recall in depression.
Deptula D; Manevitz A; Yozawitz A
J Clin Exp Neuropsychol; 1991 Nov; 13(6):854-70. PubMed ID: 1779026
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study.
Pintor L; Torres X; Navarro V; Martinez de Osaba MA; Matrai S; Gastó C
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1027-33. PubMed ID: 17433515
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients.
Kiive E; Maaroos J; Shlik J; Tõru I; Harro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1007-13. PubMed ID: 15380861
[TBL] [Abstract][Full Text] [Related]
5. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication.
Takebayashi M; Kagaya A; Uchitomi Y; Kugaya A; Muraoka M; Yokota N; Horiguchi J; Yamawaki S
J Neural Transm (Vienna); 1998; 105(4-5):537-42. PubMed ID: 9720981
[TBL] [Abstract][Full Text] [Related]
6. The cortisol response to clonidine in acute and remitted depressed men.
Trestman RL; Coccaro EF; Mitropoulou V; Gabriel SM; Horvath T; Siever LJ
Biol Psychiatry; 1993 Sep; 34(6):373-9. PubMed ID: 8218604
[TBL] [Abstract][Full Text] [Related]
7. Correlation between plasma levels of glutamate, alanine and serine with severity of depression.
Mitani H; Shirayama Y; Yamada T; Maeda K; Ashby CR; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1155-8. PubMed ID: 16707201
[TBL] [Abstract][Full Text] [Related]
8. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
9. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Stewart JW; Quitkin FM; McGrath PJ; Klein DF
J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole administration in hypercortisolemic depression.
Wolkowitz OM; Reus VI; Manfredi F; Ingbar J; Brizendine L; Weingartner H
Am J Psychiatry; 1993 May; 150(5):810-2. PubMed ID: 8480829
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic yield of basal cortisol in a sample of depressed patients].
Almoguera I; Cabranes JA; Ayuso JL; García-Camba E
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(2):91-4. PubMed ID: 4061157
[No Abstract] [Full Text] [Related]
12. Increased plasma nitric oxide level associated with suicide attempt in depressive patients.
Kim YK; Paik JW; Lee SW; Yoon D; Han C; Lee BH
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1091-6. PubMed ID: 16725247
[TBL] [Abstract][Full Text] [Related]
13. The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density.
Furlan PM; Ten Have T; Cary M; Zemel B; Wehrli F; Katz IR; Gettes DR; Evans DL
Biol Psychiatry; 2005 Apr; 57(8):911-7. PubMed ID: 15820712
[TBL] [Abstract][Full Text] [Related]
14. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients.
Carter C; Robertson L; Nordahl T; Chaderjian M; Kraft L; O'Shora-Celaya L
Biol Psychiatry; 1996 Nov; 40(9):930-2. PubMed ID: 8896783
[No Abstract] [Full Text] [Related]
15. [Cortisol secretion rate 16 hours after dexamethasone administration in patients with major depression].
Wichowicz H; Landowski J; Sowiński P
Psychiatr Pol; 1997; 31(4):471-7. PubMed ID: 9527690
[TBL] [Abstract][Full Text] [Related]
16. Depression in patients with schizophrenia during an acute psychotic episode.
Tapp A; Kilzieh N; Wood AE; Raskind M; Tandon R
Compr Psychiatry; 2001; 42(4):314-8. PubMed ID: 11458306
[TBL] [Abstract][Full Text] [Related]
17. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression.
Koenigsberg HW; Teicher MH; Mitropoulou V; Navalta C; New AS; Trestman R; Siever LJ
J Psychiatr Res; 2004; 38(5):503-11. PubMed ID: 15380401
[TBL] [Abstract][Full Text] [Related]
18. Impairment of story memory organization in patients with schizophrenia.
Matsui M; Sumiyoshi T; Abe R; Kato K; Yuuki H; Kurachi M
Psychiatry Clin Neurosci; 2007 Aug; 61(4):437-40. PubMed ID: 17610671
[TBL] [Abstract][Full Text] [Related]
19. [Oxidative modification of blood proteins in patients with psychiatric disorders (depression, depersonalization)].
Dubinina EE; Morozova MG; Leonova NV; Gamper NL; Soliternova IB; Nuller IuL; Butoma GB; Kovrugina SV
Vopr Med Khim; 2000; 46(4):398-409. PubMed ID: 11075423
[TBL] [Abstract][Full Text] [Related]
20. [Working capacity of the depressed patient sent to psychiatric treatment].
Viinamäki H; Tanskanen A; Antikainen R; Haatainen K; Honkalampi K; Koivumaa-Honkanen H; Hintikka J; Lehtonen J
Duodecim; 1998; 114(24):2575-80. PubMed ID: 11757130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
